Logo image of ANGO

ANGIODYNAMICS INC (ANGO) Stock Price, Quote, News and Overview

NASDAQ:ANGO - Nasdaq - US03475V1017 - Common Stock - Currency: USD

8.99  +0.3 (+3.45%)

After market: 8.99 0 (0%)

ANGO Quote, Performance and Key Statistics

ANGIODYNAMICS INC

NASDAQ:ANGO (7/21/2025, 8:00:00 PM)

After market: 8.99 0 (0%)

8.99

+0.3 (+3.45%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High13.5
52 Week Low5.83
Market Cap365.08M
Shares40.61M
Float37.44M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)10-01 2025-10-01
IPO05-27 2004-05-27


ANGO short term performance overview.The bars show the price performance of ANGO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

ANGO long term performance overview.The bars show the price performance of ANGO in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of ANGO is 8.99 USD. In the past month the price decreased by -10.28%. In the past year, price increased by 17.52%.

ANGIODYNAMICS INC / ANGO Daily stock chart

ANGO Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.39 216.47B
ISRG INTUITIVE SURGICAL INC 67.55 184.99B
BSX BOSTON SCIENTIFIC CORP 38.44 153.54B
SYK STRYKER CORP 30.91 148.02B
MDT MEDTRONIC PLC 16.31 114.93B
BDX BECTON DICKINSON AND CO 12.44 50.25B
EW EDWARDS LIFESCIENCES CORP 29.45 44.91B
IDXX IDEXX LABORATORIES INC 45.69 41.89B
RMD RESMED INC 28.75 38.28B
GEHC GE HEALTHCARE TECHNOLOGY 16.12 33.96B
DXCM DEXCOM INC 50.93 32.95B
PHG KONINKLIJKE PHILIPS NVR- NY 15.34 23.63B

About ANGO

Company Profile

ANGO logo image AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 748 full-time employees. The company went IPO on 2004-05-27. The firm is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. The company designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Company Info

ANGIODYNAMICS INC

14 Plaza Drive

Latham NEW YORK 12110 US

CEO: James C. Clemmer

Employees: 748

ANGO Company Website

ANGO Investor Relations

Phone: 15187981215

ANGIODYNAMICS INC / ANGO FAQ

What is the stock price of ANGIODYNAMICS INC today?

The current stock price of ANGO is 8.99 USD. The price increased by 3.45% in the last trading session.


What is the ticker symbol for ANGIODYNAMICS INC stock?

The exchange symbol of ANGIODYNAMICS INC is ANGO and it is listed on the Nasdaq exchange.


On which exchange is ANGO stock listed?

ANGO stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ANGIODYNAMICS INC stock?

9 analysts have analysed ANGO and the average price target is 16.66 USD. This implies a price increase of 85.32% is expected in the next year compared to the current price of 8.99. Check the ANGIODYNAMICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ANGIODYNAMICS INC worth?

ANGIODYNAMICS INC (ANGO) has a market capitalization of 365.08M USD. This makes ANGO a Small Cap stock.


How many employees does ANGIODYNAMICS INC have?

ANGIODYNAMICS INC (ANGO) currently has 748 employees.


What are the support and resistance levels for ANGIODYNAMICS INC (ANGO) stock?

ANGIODYNAMICS INC (ANGO) has a support level at 8.68 and a resistance level at 9.42. Check the full technical report for a detailed analysis of ANGO support and resistance levels.


Is ANGIODYNAMICS INC (ANGO) expected to grow?

The Revenue of ANGIODYNAMICS INC (ANGO) is expected to grow by 6.35% in the next year. Check the estimates tab for more information on the ANGO EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ANGIODYNAMICS INC (ANGO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ANGIODYNAMICS INC (ANGO) stock pay dividends?

ANGO does not pay a dividend.


When does ANGIODYNAMICS INC (ANGO) report earnings?

ANGIODYNAMICS INC (ANGO) will report earnings on 2025-10-01.


What is the Price/Earnings (PE) ratio of ANGIODYNAMICS INC (ANGO)?

ANGIODYNAMICS INC (ANGO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).


What is the Short Interest ratio of ANGIODYNAMICS INC (ANGO) stock?

The outstanding short interest for ANGIODYNAMICS INC (ANGO) is 6.6% of its float. Check the ownership tab for more information on the ANGO short interest.


ANGO Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to ANGO. When comparing the yearly performance of all stocks, ANGO turns out to be only a medium performer in the overall market: it outperformed 52.77% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ANGO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ANGO. The financial health of ANGO is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ANGO Financial Highlights

Over the last trailing twelve months ANGO reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 61.54% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -12.13%
ROE -18.58%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%12.93%
EPS 1Y (TTM)61.54%
Revenue 1Y (TTM)-3.76%

ANGO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ANGO. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of -54.14% and a revenue growth 6.35% for ANGO


Ownership
Inst Owners91.01%
Ins Owners5.34%
Short Float %6.6%
Short Ratio4.43
Analysts
Analysts84.44
Price Target16.66 (85.32%)
EPS Next Y-54.14%
Revenue Next Year6.35%